Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29179522
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Oncotarget
2017 ; 8
(51
): 89315-89325
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Acetylation and deacetylation in cancer stem-like cells
#MMPMID29179522
Liu N
; Li S
; Wu N
; Cho KS
Oncotarget
2017[Oct]; 8
(51
): 89315-89325
PMID29179522
show ga
Cancer stem-like cell (CSC) model has been established to investigate the
underlying mechanisms of tumor initiation and progression. The imbalance between
acetylation and deacetylation of histone or non-histone proteins, one of the
important epigenetic modification processes, is closely associated with a wide
variety of diseases including cancer. Acetylation and deacetylation are involved
in various stemness-related signal pathways and drive the regulation of
self-renewal and differentiation in normal developmental processes. Therefore, it
is critical to explore their role in the maintenance of cancer stem-like cell
traits. Here, we will review the extensive dysregulations of acetylation found in
cancers and summarize their functional roles in sustaining CSC-like properties.
Additionally, the use of deacetyltransferase inhibitors as an effective
therapeutic strategy against CSCs is also discussed.